BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 23562747)

  • 1. Leptin-cytokine crosstalk in breast cancer.
    Newman G; Gonzalez-Perez RR
    Mol Cell Endocrinol; 2014 Jan; 382(1):570-582. PubMed ID: 23562747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch, IL-1 and leptin crosstalk outcome (NILCO) is critical for leptin-induced proliferation, migration and VEGF/VEGFR-2 expression in breast cancer.
    Guo S; Gonzalez-Perez RR
    PLoS One; 2011; 6(6):e21467. PubMed ID: 21731759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells.
    Guo S; Liu M; Wang G; Torroella-Kouri M; Gonzalez-Perez RR
    Biochim Biophys Acta; 2012 Apr; 1825(2):207-22. PubMed ID: 22289780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin's Pro-Angiogenic Signature in Breast Cancer.
    Gonzalez-Perez RR; Lanier V; Newman G
    Cancers (Basel); 2013 Sep; 5(3):1140-62. PubMed ID: 24202338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Notch, IL-1 and leptin expression in colorectal cancer.
    Erkasap N; Ozyurt R; Ozkurt M; Erkasap S; Yasar F; Ihtiyar E; Ciftci E; Canaz F; Colak E
    Exp Ther Med; 2021 Jun; 21(6):600. PubMed ID: 33884038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin-induced Notch and IL-1 signaling crosstalk in endometrial adenocarcinoma is associated with invasiveness and chemoresistance.
    Daley-Brown D; Harbuzariu A; Kurian AA; Oprea-Ilies G; Gonzalez-Perez RR
    World J Clin Oncol; 2019 Jun; 10(6):222-233. PubMed ID: 31367531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.
    Giordano C; Chemi F; Panza S; Barone I; Bonofiglio D; Lanzino M; Cordella A; Campana A; Hashim A; Rizza P; Leggio A; Győrffy B; Simões BM; Clarke RB; Weisz A; Catalano S; Andò S
    Oncotarget; 2016 Jan; 7(2):1262-75. PubMed ID: 26556856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NILCO biomarkers in breast cancer from Chinese patients.
    Colbert LS; Wilson K; Kim S; Liu Y; Oprea-Ilies G; Gillespie C; Dickson T; Newman G; Gonzalez-Perez RR
    BMC Cancer; 2014 Apr; 14():249. PubMed ID: 24716804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancer.
    Lipsey CC; Harbuzariu A; Daley-Brown D; Gonzalez-Perez RR
    World J Methodol; 2016 Mar; 6(1):43-55. PubMed ID: 27019796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multifactorial role of leptin in driving the breast cancer microenvironment.
    Andò S; Catalano S
    Nat Rev Endocrinol; 2011 Nov; 8(5):263-75. PubMed ID: 22083089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets.
    Khan S; Shukla S; Sinha S; Meeran SM
    Cytokine Growth Factor Rev; 2013 Dec; 24(6):503-13. PubMed ID: 24210902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of angiogenesis via Notch signaling in breast cancer and cancer stem cells.
    Zhou W; Wang G; Guo S
    Biochim Biophys Acta; 2013 Dec; 1836(2):304-20. PubMed ID: 24183943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin signaling molecular actions and drug target in hepatocellular carcinoma.
    Jiang N; Sun R; Sun Q
    Drug Des Devel Ther; 2014; 8():2295-302. PubMed ID: 25484575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and molecular crosstalk between leptin receptor and estrogen receptor-{alpha} in breast cancer: molecular basis for a novel therapeutic setting.
    Fusco R; Galgani M; Procaccini C; Franco R; Pirozzi G; Fucci L; Laccetti P; Matarese G
    Endocr Relat Cancer; 2010 Jun; 17(2):373-82. PubMed ID: 20410173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Cachexia and breast cancer stem cell signalling - A crosstalk of signalling molecules.
    Shivnani P; Shekhawat S; Prajapati A
    Cell Signal; 2023 Oct; 110():110847. PubMed ID: 37557973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer.
    Rene Gonzalez R; Watters A; Xu Y; Singh UP; Mann DR; Rueda BR; Penichet ML
    Breast Cancer Res; 2009; 11(3):R36. PubMed ID: 19531256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment.
    Habanjar O; Bingula R; Decombat C; Diab-Assaf M; Caldefie-Chezet F; Delort L
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies.
    Jardé T; Caldefie-Chézet F; Goncalves-Mendes N; Mishellany F; Buechler C; Penault-Llorca F; Vasson MP
    Endocr Relat Cancer; 2009 Dec; 16(4):1197-210. PubMed ID: 19661131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imbalance in leptin-adiponectin levels and leptin receptor expression as chief contributors to triple negative breast cancer progression in Northeast India.
    Sultana R; Kataki AC; Borthakur BB; Basumatary TK; Bose S
    Gene; 2017 Jul; 621():51-58. PubMed ID: 28414093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linkage Between Obesity Leptin and Breast Cancer.
    Atoum MF; Alzoughool F; Al-Hourani H
    Breast Cancer (Auckl); 2020; 14():1178223419898458. PubMed ID: 31975779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.